← Leaderboards
Charlotte Jane Sumner
Johns Hopkins University
$12,001,647
Attributed
$12,001,647
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,001,647 · 7
By mechanism
R01$5,669,135 · 4
R35$5,290,574 · 1
K22$570,360 · 1
R21$471,578 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Thomas M Brushart$4,856,572
- Beth B Murinson$774,554
- J. Marie Hardwick$15,638,274
- Vassilis E Koliatsos$10,364,762
- Douglas A Kerr$3,569,968
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationGenesSpinal Muscular AtrophyMuscle WeaknessMotorMotor NeuronsMotor Neuron DiseaseInheritedPhenotypeTherapeutic TargetInsightPathologyCellsProteinsInduced Pluripotent Stem CellImpairmentMortalityGeneticHistone Deacetylase InhibitorMolecularNovel Therapeutic InterventionBasePharmaceutical PreparationsNeonatal
Grant awards (26)
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$1,047,692
R35 · FY2025 · NS · contact PI
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$1,016,262
R35 · FY2024 · NS · contact PI
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$1,002,012
R35 · FY2023 · NS · contact PI
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$1,002,012
R35 · FY2022 · NS · contact PI
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$163,750
R35 · FY2022 · NS · contact PI
Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies$1,058,846
R35 · FY2021 · NS · contact PI
TRPV4 links the blood-neural barrier to motor neuron dysfunction$496,963
R01 · FY2020 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$426,710
R01 · FY2020 · NS · contact PI
Impaired axon development in SMA$417,505
R01 · FY2020 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$426,710
R01 · FY2019 · NS · contact PI
Impaired axon development in SMA$417,505
R01 · FY2019 · NS · contact PI
Impaired axon development in SMA$417,346
R01 · FY2018 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$322,986
R01 · FY2018 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$496,813
R01 · FY2017 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$456,588
R01 · FY2016 · NS · contact PI
Targeting a SMN lncRNA for the treatment of SMA$46,708
R01 · FY2016 · NS · contact PI
A model of TRPV4 channelopathy$207,789
R21 · FY2015 · NS · contact PI
A model of TRPV4 channelopathy$263,789
R21 · FY2014 · NS · contact PI
Muscle and neuromuscular junctions in spinal muscular atrophy$333,192
R01 · FY2013 · NS · contact PI
Muscle and neuromuscular junctions in spinal muscular atrophy$345,526
R01 · FY2012 · NS · contact PI
Muscle and neuromuscular junctions in spinal muscular atrophy$345,768
R01 · FY2011 · NS · contact PI
Muscle and neuromuscular junctions in spinal muscular atrophy$349,529
R01 · FY2010 · NS · contact PI
Muscle and neuromuscular junctions in spinal muscular atrophy$369,286
R01 · FY2009 · NS · contact PI
Regulation of the survival motor neuron gene$190,900
K22 · FY2008 · NS · contact PI
Regulation of the survival motor neuron gene$190,900
K22 · FY2007 · NS · contact PI
Regulation of the survival motor neuron gene$188,560
K22 · FY2006 · NS · contact PI